BBLG Q2 2018 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$860,000

Net Income

-$1M

EPS (Diluted)

$-1028.52

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$666,840

Free Cash Flow

-$666,840

Stock-Based Comp.

$195,795

Balance Sheet

Total Assets

$377,744

Total Liabilities

$10M

Stockholders' Equity

-$9M

Cash & Equivalents

$304,564

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$860,000	$2M	-143.5%
Net Income	-$1M	$1M	-224.3%